Cyclic ADP-Ribose

"Cyclic ADP-Ribose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A pyridine nucleotide that mobilizes CALCIUM. It is synthesized from nicotinamide adenine dinucleotide (NAD) by ADP RIBOSE CYCLASE.

Descriptor ID	D036563
MeSH Number(s)	D03.633.100.759.646.138.124.070.125.195 D09.408.620.569.070.125.195 D13.695.667.138.124.070.125.195 D13.695.827.068.124.070.125.195 D13.695.827.708.070.125.195
Concept/Terms	Cyclic ADP-Ribose Cyclic ADP-Ribose ADP-Ribose, Cyclic Cyclic ADP Ribose cADP-Ribose cADP Ribose Adenosine Diphosphate Ribose, Cyclic Cyclic ADPribose ADPribose, Cyclic cADPR Cyclic Adenosine Diphosphate Ribose

Below are MeSH descriptors whose meaning is more general than "Cyclic ADP-Ribose".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, Fused-Ring [D03.633]
Heterocyclic Compounds, 2-Ring [D03.633.100]
Purines [D03.633.100.759]
Purine Nucleotides [D03.633.100.759.646]
Adenine Nucleotides [D03.633.100.759.646.138]
Adenosine Diphosphate [D03.633.100.759.646.138.124]
Adenosine Diphosphate Sugars [D03.633.100.759.646.138.124.070]
Adenosine Diphosphate Ribose [D03.633.100.759.646.138.124.070.125]
Cyclic ADP-Ribose [D03.633.100.759.646.138.124.070.125.195]
Carbohydrates [D09]
Glycosides [D09.408]
Nucleotides [D09.408.620]
Nucleoside Diphosphate Sugars [D09.408.620.569]
Adenosine Diphosphate Sugars [D09.408.620.569.070]
Adenosine Diphosphate Ribose [D09.408.620.569.070.125]
Cyclic ADP-Ribose [D09.408.620.569.070.125.195]
Nucleic Acids, Nucleotides, and Nucleosides [D13]
Nucleotides [D13.695]
Purine Nucleotides [D13.695.667]
Adenine Nucleotides [D13.695.667.138]
Adenosine Diphosphate [D13.695.667.138.124]
Adenosine Diphosphate Sugars [D13.695.667.138.124.070]
Adenosine Diphosphate Ribose [D13.695.667.138.124.070.125]
Cyclic ADP-Ribose [D13.695.667.138.124.070.125.195]
Ribonucleotides [D13.695.827]
Adenine Nucleotides [D13.695.827.068]
Adenosine Diphosphate [D13.695.827.068.124]
Adenosine Diphosphate Sugars [D13.695.827.068.124.070]
Adenosine Diphosphate Ribose [D13.695.827.068.124.070.125]
Cyclic ADP-Ribose [D13.695.827.068.124.070.125.195]
Nucleoside Diphosphate Sugars [D13.695.827.708]
Adenosine Diphosphate Sugars [D13.695.827.708.070]
Adenosine Diphosphate Ribose [D13.695.827.708.070.125]
Cyclic ADP-Ribose [D13.695.827.708.070.125.195]

Below are MeSH descriptors whose meaning is related to "Cyclic ADP-Ribose".

Below are MeSH descriptors whose meaning is more specific than "Cyclic ADP-Ribose".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cyclic ADP-Ribose" by people in this website by year, and whether "Cyclic ADP-Ribose" was a major or minor topic of these publications.

Bar chart showing 11 publications over 6 distinct years, with a maximum of 6 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	5	6
2012	1	0	1
2014	0	1	1
2018	1	0	1
2020	1	0	1
2024	1	0	1

Below are the most recent publications written about "Cyclic ADP-Ribose" by people in Profiles.

Dogan S, Walseth TF, Guvenc Tuna B, U?ar E, Kannan MS, Deshpande DA. CD38/cADPR-mediated calcium signaling in a human myometrial smooth muscle cell line, PHM1. IUBMB Life. 2024 12; 76(12):1223-1233.

View in: PubMed
Guedes AG, Dileepan M, Jude JA, Deshpande DA, Walseth TF, Kannan MS. Role of CD38/cADPR signaling in obstructive pulmonary diseases. Curr Opin Pharmacol. 2020 04; 51:29-33.

View in: PubMed
Deshpande DA, Guedes AGP, Graeff R, Dogan S, Subramanian S, Walseth TF, Kannan MS. CD38/cADPR Signaling Pathway in Airway Disease: Regulatory Mechanisms. Mediators Inflamm. 2018; 2018:8942042.

View in: PubMed
Guedes AG, Deshpande DA, Dileepan M, Walseth TF, Panettieri RA, Subramanian S, Kannan MS. CD38 and airway hyper-responsiveness: studies on human airway smooth muscle cells and mouse models. Can J Physiol Pharmacol. 2015 Feb; 93(2):145-53.

View in: PubMed
Lewis AM, Aley PK, Roomi A, Thomas JM, Masgrau R, Garnham C, Shipman K, Paramore C, Bloor-Young D, Sanders LE, Terrar DA, Galione A, Churchill GC. ?-Adrenergic receptor signaling increases NAADP and cADPR levels in the heart. Biochem Biophys Res Commun. 2012 Oct 19; 427(2):326-9.

View in: PubMed
Deshpande DA, White TA, Guedes AG, Milla C, Walseth TF, Lund FE, Kannan MS. Altered airway responsiveness in CD38-deficient mice. Am J Respir Cell Mol Biol. 2005 Feb; 32(2):149-56.

View in: PubMed
Kotlikoff MI, Kannan MS, Solway J, Deng KY, Deshpande DA, Dowell M, Feldman M, Green KS, Ji G, Johnston R, Lakser O, Lee J, Lund FE, Milla C, Mitchell RW, Nakai J, Rishniw M, Walseth TF, White TA, Wilson J, Xin HB, Woodruff PG. Methodologic advancements in the study of airway smooth muscle. J Allergy Clin Immunol. 2004 Aug; 114(2 Suppl):S18-31.

View in: PubMed
Tliba O, Panettieri RA, Tliba S, Walseth TF, Amrani Y. Tumor necrosis factor-alpha differentially regulates the expression of proinflammatory genes in human airway smooth muscle cells by activation of interferon-beta-dependent CD38 pathway. Mol Pharmacol. 2004 Aug; 66(2):322-9.

View in: PubMed
Amrani Y, Tliba O, Deshpande DA, Walseth TF, Kannan MS, Panettieri RA. Bronchial hyperresponsiveness: insights into new signaling molecules. Curr Opin Pharmacol. 2004 Jun; 4(3):230-4.

View in: PubMed
Dogan S, Deshpande DA, Kannan MS, Walseth TF. Changes in CD38 expression and ADP-ribosyl cyclase activity in rat myometrium during pregnancy: influence of sex steroid hormones. Biol Reprod. 2004 Jul; 71(1):97-103.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement